MedTrace Logo

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

NCT03796559 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to provide prospective evidence that the use of Magseed/Sentimag in marking axillary lymph nodes and guiding surgical localization in patients with breast cancer following neo-adjuvant chemotherapy (NAC) is effective.

Conditions

Interventions

DEVICE

Magseed Marker

Implantable Magseed marker for marking lesions in soft tissue, detected using the Sentimag handheld probe.

Sponsors & Collaborators

  • Endomagnetics Ltd.

    lead INDUSTRY

Principal Investigators

  • Abigail Caudle, MD, MS · MD Anderson Cancer Center, Houston, TX

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2026-02-28
Completion
2026-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796559 on ClinicalTrials.gov